Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Molecular features of the cytolytic pore-forming bacterial protein toxins.

Alouf JE.

Folia Microbiol (Praha). 2003;48(1):5-16. Review.

PMID:
12744072
2.

Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.

Alouf JE, Müller-Alouf H.

Int J Med Microbiol. 2003 Feb;292(7-8):429-40. Review.

PMID:
12635926
3.

The use of chimeric bacterial and plant protein toxins for targeted chemotherapy.

Alouf JE.

Clin Microbiol Infect. 1998 Jul;4(7):357-358. No abstract available.

4.

Superantigen bacterial toxins: state of the art.

Müller-Alouf H, Carnoy C, Simonet M, Alouf JE.

Toxicon. 2001 Nov;39(11):1691-701. Review.

PMID:
11595632
5.

Pore-forming bacterial protein toxins: an overview.

Alouf JE.

Curr Top Microbiol Immunol. 2001;257:1-14. No abstract available.

PMID:
11417117
6.

Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Müller-Alouf H, Proft T, Zollner TM, Gerlach D, Champagne E, Desreumaux P, Fitting C, Geoffroy-Fauvet C, Alouf JE, Cavaillon JM.

Infect Immun. 2001 Jun;69(6):4141-5.

7.

Cholesterol-binding cytolytic protein toxins.

Alouf JE.

Int J Med Microbiol. 2000 Oct;290(4-5):351-6. Review.

PMID:
11111910
8.

Bacterial protein toxins. An overview.

Alouf JE.

Methods Mol Biol. 2000;145:1-26. Review. No abstract available.

PMID:
10820713
9.

Streptococcal pyrogenic exotoxin A (SPE A) superantigen induced production of hematopoietic cytokines, IL-12 and IL-13 by human peripheral blood mononuclear cells.

Müller-Alouf H, Gerlach D, Desreumaux P, Leportier C, Alouf JE, Capron M.

Microb Pathog. 1997 Nov;23(5):265-72.

PMID:
9405204
10.

Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.

Müller-Alouf H, Geoffroy C, Geslin P, Bouvet A, Felten A, Günther E, Ozegowski JH, Alouf JE.

Zentralbl Bakteriol. 1997 Oct;286(3):421-33.

PMID:
9361388
11.

Cytokine profile of human peripheral blood mononucleated cells stimulated with a novel streptococcal superantigen, SPEA, SPEC and group A streptococcal cells.

Müller-Alouf H, Capron M, Alouf JE, Geoffroy C, Gerlach D, Ozegowski JH, Fitting C, Cavaillon JM.

Adv Exp Med Biol. 1997;418:929-31. No abstract available.

PMID:
9331802
12.

Cytokines in streptococcal infections. An opening lecture.

Cavaillon JM, Müller-Alouf H, Alouf JE.

Adv Exp Med Biol. 1997;418:869-79. Review. No abstract available.

PMID:
9331790
13.

Serotype, biotype, pyrogenic exotoxin, streptolysin O and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bacteremia and other severe infections.

Müller-Alouf H, Geoffroy C, Geslin P, Bouvet A, Felten A, Günther E, Ozegowski JH, Reichardt W, Alouf JE.

Adv Exp Med Biol. 1997;418:241-3. No abstract available.

PMID:
9331642
14.

Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation.

Holm SE, Köhler W, Kaplan EL, Schlievert PM, Alouf JE, Stevens DL, Kotb M.

Adv Exp Med Biol. 1997;418:193-9. No abstract available.

PMID:
9331631
15.

Streptococcal research at Pasteur Institute from Louis Pasteur's time to date.

Alouf JE, Horaud T.

Adv Exp Med Biol. 1997;418:7-14. No abstract available.

PMID:
9331588
16.

Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens.

Müller-Alouf H, Alouf JE, Gerlach D, Ozegowski JH, Fitting C, Cavaillon JM.

Infect Immun. 1996 Apr;64(4):1450-3.

17.
18.
20.

Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8.

König B, Köller M, Prevost G, Piemont Y, Alouf JE, Schreiner A, König W.

Infect Immun. 1994 Nov;62(11):4831-7.

21.

Bifactorial versus monofactorial molecular status of Staphylococcus aureus gamma-toxin.

Guidi-Rontani C, Fouque F, Alouf JE.

Microb Pathog. 1994 Jan;16(1):1-14.

PMID:
8057825
23.
24.

A novel membrane-acting immunotoxin, the immunolysin, with therapeutic potential.

Drobniewski FA, Watson GJ, Wawrzynczak EJ, Alouf JE, Thorpe PE.

Biochem Soc Trans. 1992 Nov;20(4):318S. No abstract available.

PMID:
1486988
25.

Cytokine production by murine cells activated by erythrogenic toxin type A superantigen of Streptococcus pyogenes.

Müller-Alouf H, Alouf JE, Gerlach D, Fitting C, Cavaillon JM.

Immunobiology. 1992 Nov;186(5):435-48.

PMID:
1286882
26.

The phosphoinositide pathway of lymphoid cells: labeling after permeabilization by alveolysin, a bacterial sulfhydryl-activated cytolysin.

Berthou L, Corvaia N, Geoffroy C, Mutel V, Launay JM, Alouf JE.

Eur J Cell Biol. 1992 Aug;58(2):377-82.

PMID:
1425773
27.

One-step purification of the serotonin transporter located at the human platelet plasma membrane.

Launay JM, Geoffroy C, Mutel V, Buckle M, Cesura A, Alouf JE, Da Prada M.

J Biol Chem. 1992 Jun 5;267(16):11344-51.

28.

Reduced virulence of a Listeria monocytogenes phospholipase-deficient mutant obtained by transposon insertion into the zinc metalloprotease gene.

Raveneau J, Geoffroy C, Beretti JL, Gaillard JL, Alouf JE, Berche P.

Infect Immun. 1992 Mar;60(3):916-21.

29.

Bacterial toxins induce heat shock proteins in human neutrophils.

Hensler T, Köller M, Alouf JE, König W.

Biochem Biophys Res Commun. 1991 Sep 16;179(2):872-9.

PMID:
1898407
30.

Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic fever.

Bahr GM, Yousof AM, Behbehani K, Majeed HA, Sakkalah S, Souan K, Jarrad I, Geoffroy C, Alouf JE.

J Clin Microbiol. 1991 Sep;29(9):1789-94.

31.

Purification and characterization of an extracellular 29-kilodalton phospholipase C from Listeria monocytogenes.

Geoffroy C, Raveneau J, Beretti JL, Lecroisey A, Vazquez-Boland JA, Alouf JE, Berche P.

Infect Immun. 1991 Jul;59(7):2382-8.

32.

The amphiphilic alpha-helix concept. Consequences on the structure of staphylococcal delta-toxin in solution and bound to lipids.

Thiaudière E, Siffert O, Talbot JC, Bolard J, Alouf JE, Dufourcq J.

Eur J Biochem. 1991 Jan 1;195(1):203-13.

35.
36.

Reaction of staphylococcal alpha-toxin with peptide-induced antibodies.

Harshman S, Alouf JE, Siffert O, Baleux F.

Infect Immun. 1989 Dec;57(12):3856-62.

37.

Modulation of leukotriene generation by pertussis toxin.

Hensler T, Raulf M, Megret F, Alouf JE, König W.

Infect Immun. 1989 Oct;57(10):3165-71.

38.

Staphylococcal alpha-toxin: a study of membrane penetration and pore formation.

Harshman S, Boquet P, Duflot E, Alouf JE, Montecucco C, Papini E.

J Biol Chem. 1989 Sep 5;264(25):14978-84.

39.
40.

Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1.

Galelli A, Anderson S, Charlot B, Alouf JE.

J Immunol. 1989 Apr 15;142(8):2855-63.

PMID:
2784816
41.

Production of thiol-dependent haemolysins by Listeria monocytogenes and related species.

Geoffroy C, Gaillard JL, Alouf JE, Berche P.

J Gen Microbiol. 1989 Mar;135(3):481-7.

PMID:
2516113
43.

Induction of tumour necrosis factor by staphylococcal toxic shock toxin 1.

de Azavedo JC, Drumm A, Jupin C, Parant M, Alouf JE, Arbuthnott JP.

FEMS Microbiol Immunol. 1988 Jul;1(2):69-74.

PMID:
3273461
44.
45.

A new kinetic approach for studying phospholipase C (Clostridium perfringens alpha toxin) activity on phospholipid monolayers.

Moreau H, Pieroni G, Jolivet-Reynaud C, Alouf JE, Verger R.

Biochemistry. 1988 Apr 5;27(7):2319-23.

PMID:
2898259
46.

Damaging effects of Clostridium perfringens delta toxin on blood platelets and their relevance to ganglioside GM2.

Jolivet-Reynaud C, Launay JM, Alouf JE.

Arch Biochem Biophys. 1988 Apr;262(1):59-66.

PMID:
3162668
47.

Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.

Jupin C, Anderson S, Damais C, Alouf JE, Parant M.

J Exp Med. 1988 Mar 1;167(3):752-61.

48.

Production, purification, and assay of streptococcal erythrogenic toxin.

Geoffroy C, Alouf JE.

Methods Enzymol. 1988;165:64-7. No abstract available.

PMID:
3231119
49.

Production, purification, and assay of streptolysin O.

Alouf JE, Geoffroy C.

Methods Enzymol. 1988;165:52-9. No abstract available.

PMID:
3231118
50.

Production, purification, and assay of streptolysin S.

Alouf JE, Loridan C.

Methods Enzymol. 1988;165:59-64. No abstract available.

PMID:
3068490

Supplemental Content

Loading ...
Support Center